PCI 3.06.26
Wallonia
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

DDL 2026
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

CDD Vault – 18.03.2025

Advertisement

Biopharma Group – 19th March 2025
news

‘Bubble boy’ gene therapy results shoot Mustang Bio’s stock up 200%

Shares in Mustang Bio soared by as much as 200% Thursday after an experimental gene therapy it holds an exclusive license to proved successful in treating children...
Continue Reading →
news

With FDA decision near, Novartis bolsters SMA gene therapy case

Treatment with Novartis' experimental gene therapy Zolgensma helped to keep alive nearly all infants with a severe form of spinal muscular atrophy who enrolled in ...
Continue Reading →
news

‘This is a cure.’ St. Jude’s gene therapy succeeds in ‘bubble boy’ disease study

A gene therapy developed by St. Jude Children's Research Hospital has shown tremendous promise to change the outlook for children with a debilitating disease that mak...
Continue Reading →
news

BI and Lilly’s diabetes drug Jardiance reverses heart failure in animal models

The SGLT2 inhibitor Jardiance is known to reduce the risk of cardiac death in patients with diabetes, and scientists a...
Continue Reading →
news

Cannabidiol could help deliver medications to the brain

Cannabidiol (CBD), a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy. Although much ...
Continue Reading →
news

Alnylam inks broad R&D deal with Regeneron

Alnylam Pharmaceuticals on Monday announced a major drug development collaboration with Regeneron, taking its expertise in RNA interference to a new partner as it ...
Continue Reading →
news

Audentes lays down marker in muscular dystrophy

Audentes Therapeutics has licensed an experimental project from Nationwide Children's Hospital that the company says will stimulate production of a near-complete ...
Continue Reading →
news

AskBio reels in $235M to ramp up gene therapy clinical trials, manufacturing

Since its founding in 2001, the company has spun out and sold two companies: hemophilia-focused Chatham Therapeutics and...
Continue Reading →
news

Research Using CRISPR to identify a new cancer drug target

Two separate Nature studies have pinpointed WRN as a promising drug target for MSI tumors. (kirstypargeter/iStock/Gett...
Continue Reading →
news

Ebola survivors’ immune responses offer clues for vaccine development

French scientists characterized T cells against Ebola virus among survivors in a finding they believe could guide the ...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro